Fecal transplant for chronic diarrhea in adults
Part of Digestive system clinical trials.
This trial tests a new way to give a fecal transplant (called washed microbiota transplantation) to adults with long-term diarrhea. The goal is to see if it helps improve stool consistency and reduce how often you need to go to the bathroom.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have had loose or watery stools (Bristol types 5, 6, or 7) at least 3 times a day for more than 4 weeks, or go through cycles of diarrhea.
- You have not had part of your intestine removed.
- You do not have another known cause for your diarrhea, such as inflammatory bowel disease, an active infection, or a condition affecting your digestion.
- You have not taken antibiotics, antifungals, or antivirals in the last 2 weeks.
- You have not used probiotics, prebiotics, or fermented products (like yogurt) in the last 2 weeks.
- You are not pregnant, breastfeeding, or planning pregnancy within 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether putting stool (fecal microbiota) from a donor into your bowel can improve symptoms in people with IBS who are not IBS-C. It may help by changing the gut bacteria that can influence IBS symptoms.
This trial tests a new way to do a fecal transplant (called washed microbiota transplantation) to help people with long-term constipation. It uses a special device to prepare the transplant, and the goal is to see how safe and effective it is.
This trial tests a treatment called washed microbiota transplantation (a procedure that delivers healthy gut bacteria to your colon) for adults with chronic constipation. The goal is to see if it can improve bowel movements without the need for laxatives.
This trial tests if a fecal microbiota transplant combined with nutritional support can improve chronic constipation that hasn't gotten better with standard treatments. It's a small early study to see if the approach is safe and works.
This Phase 1 study tests defined fecal microbiota (healthy gut bacteria) given to people with C. difficile diarrhea that didn’t go away or came back soon after antibiotics. It may help by restoring a healthier balance of gut bacteria so the infection can stop recurring.
This trial studies using a fecal microbiota transplant (FMT)—healthy gut bacteria moved from a screened donor—to help treat recurring or hard-to-control C. difficile infection. It may help restore a healthier gut environment when standard treatments keep failing or the infection returns.
Hear when a new Diarrhea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.